Frankfurt - Delayed Quote EUR
Verona Pharma plc (I9SA.F)
62.60
+0.40
+(0.64%)
As of 9:51:41 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-122,203
-122,203
-50,222
-59,862
-33,254
Investing Cash Flow
-580
-580
--
-29
-12
Financing Cash Flow
250,779
250,779
92,869
140,818
-6,117
End Cash Position
399,757
399,757
271,772
227,827
148,380
Income Tax Paid Supplemental Data
642
642
1,245
120
1
Interest Paid Supplemental Data
10,330
10,330
2,006
348
215
Capital Expenditure
-580
-580
--
-29
-12
Issuance of Capital Stock
97,496
97,496
56,909
149,797
733
Issuance of Debt
122,500
122,500
38,708
10,000
--
Repayment of Debt
-52,256
-52,256
--
-5,000
--
Free Cash Flow
-122,783
-122,783
-50,222
-59,891
-33,266
12/31/2021 - 8/27/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
UR8.BE UroGen Pharma Ltd. R
10.00
-1.96%
GON.F Geron Corporation
1.1860
-2.79%
ZH6.BE Biohaven Ltd. R
20.00
-0.99%
49BA.BE BeiGene Ltd
222.00
0.00%
PTCT PTC Therapeutics, Inc.
49.95
+0.87%
MBRX Moleculin Biotech, Inc.
1.0300
+1.98%
IFRX InflaRx N.V.
1.7300
-6.49%
NUVB Nuvation Bio Inc.
2.4600
+8.37%
MESO Mesoblast Limited
12.05
+0.92%
AKRO Akero Therapeutics, Inc.
44.87
-0.97%